[1]谢 宁,李红岩,韩晓云.加味杞菊地黄汤联合西药治疗子痫前期疗效及对患者外周血sFlt/PIGF和妊娠结局的影响[J].陕西中医,2021,(9):1189-1192.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.009]
　XIE Ning,LI Hongyan,HAN Xiaoyun.Effect of modified Qiju Dihuang decoction combined with western medicine in preeclampsia and its influence on sFlt/PIGF in peripheral blood and pregnancy outcome[J].,2021,(9):1189-1192.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.009]
点击复制

加味杞菊地黄汤联合西药治疗子痫前期疗效及对患者外周血sFlt/PIGF和妊娠结局的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1189-1192
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Effect of modified Qiju Dihuang decoction combined with western medicine in preeclampsia and its influence on sFlt/PIGF in peripheral blood and pregnancy outcome
作者:
谢 宁1 ; 李红岩2; 韩晓云1
(1.济宁医学院附属医院产科,山东 济宁 272001; 2.邹城市人民医院产科,山东 邹城 273500)
Author(s):
XIE Ning; LI Hongyan; HAN Xiaoyun
(Department of Obstetrics,Affiliated Hospital of Jining Medical University,Jining 272001,China)
关键词:
子痫前期;  加味杞菊地黄汤;  硫酸镁;  硝苯地平缓释片;  血清sFlt/PIGF;  妊娠结局
Keywords:
Preeclampsia;  Modified Qiju Dihuang decoction;  Magnesium sulfate;  Nifedipine sustained-release tablets;  Serum sFlt/PIGF;  Pregnancy outcome
分类号:
R 271.4
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.009
文献标志码:
A
摘要:
目的:探讨加味杞菊地黄汤联合西药治疗子痫前期疗效及对患者外周血可溶性Fms样酪氨酸激酶1(sFlt)/胎盘生长因子(PIGF)水平和妊娠结局的影响。方法:将90例子痫前期患者随机分为对照组(n=45)、观察组(n=45)。选择同期健康孕妇30例设为空白对照组。对照组采用硫酸镁联合硝苯地平缓释片治疗,观察组联合加味杞菊地黄汤治疗,比较三组血清sFlt/PIGF、中医证候积分、血压水平、妊娠结局、疗效及不良反应发生情况。结果:治疗后,观察组血清sFlt/PIGF、中医证候积分、收缩压(SBP)、舒张压(DBP)水平低于对照组(均P<0.05),观察组血sFlt/PIGF、中医证候积分高于空白对照组(均P<0.05)。三组不良妊娠结局发生率比较,差异无统计学意义(均P>0.05)。观察组总有效率高于对照组(P<0.05),两组用药期间恶心呕吐、腹泻便秘、心悸等不良反应发生率比较,差异无统计学意义(均P>0.05)。结论:加味杞菊地黄汤联合西药能降低子痫前期患者血清sFlt/PIGF、中医证候积分、血压水平,改善妊娠结局,提高临床疗效,安全性较高。
Abstract:
Objective:To explore effect of modified Qiju Dihuang decoction combined with western medicine in patients with preeclampsia and influence on peripheral blood soluble Fms-like tyrosine kinase 1(sFlt)/placental growth factor(PIGF)levels and pregnancy outcome.Methods:90 patients with preeclampsia were randomly divided into control group(n=45)and observation group(n=45).30 healthy pregnant women during the same period were selected as the blank control group.The control group was treated with magnesium sulfate combined with nifedipine sustained-release tablets,and the observation group was treated with modified Qiju Dihuang decoction on the basis of the control group.The serum sFlt/PIGF,TCM syndrome score,blood pressure level,pregnancy outcome,curative effect and incidence of adverse reactions were compared among the three groups.Results:After treatment,serum sFlt/PIGF,TCM syndrome scores,SBP,and DBP in the observation group were significant lower than those in the control group(all P<0.05).The serum sFlt/PIGF and TCM syndrome scores of the observation group were significant higher than those in the blank control group(all P<0.05).The incidence of adverse pregnancy outcomes in the three groups were not statistically significant(all P>0.05).After treatment,the efficiency of the observation group was significant higher than the control group(P<0.05).There was no significant difference in adverse reactions of nausea and vomiting,diarrhea,constipation,and palpitations between the observation group and the control group(all P>0.05).Conclusion:Modified Qiju Dihuang decoction combined with western medicine can reduce serum sFlt/PIGF,TCM syndrome scores and blood pressure levels in patients with preeclampsia,and can improve pregnancy outcome,clinical efficacy,and better security.

参考文献/References:

[1] 史娜娜,周芳芳.PP13、PIGF、sFlt-1联合检测诊断及预测早期子痫前期价值[J].中国计划生育学杂志,2020,28(5):734-738.
[2] 张俊绘,王桂香,王婷婷,等.微小RNAlet-7在子痫前期患者中的表达及相关性分析研究[J].中国妇产科临床杂志,2020,21(3):11-13.
[3] 黄丽琼,郑 波,张元珍,等.2-甲氧雌二醇在早发型子痫前期患者中的表达及临床意义[J].陕西医学杂志,2019,48(2):208-212.
[4] Han C,Wang C,Chen Y,et al.Placenta-derived extracellular vesicles induce preeclampsia in mouse models[J].Haematologica,2019,105(6):226-229.
[5] 于红艳,方开英,张瑛瑜,等.孕妇外周血中妊娠早期免疫生物标志物对子痫前期的预测价值研究[J].中国性科学,2020,29(5):80-85.
[6] 任春丽,唐兴国,张玉芳,等.血清TLR4及MFG-E8与子痫前期患者表达及发生早期肾损伤的关系[J].中国实验诊断学,2020,24(11):1770-1773.
[7] Nardhy A,Gomez L,Kenichiro C,et al.Inflammasomes:Their role in normal and complicated pregnancies[J].Journal of Immunology,2019,203(11):2757-2769.
[8] 谢 幸.妇产科学[M].北京:人民卫生出版社,2013:47-108.
[9] 王丽颖,刘孟宇,宇文亚,等. 《中医妇科常见病诊疗指南》临床应用评价研究[J].中国中药杂志,2017,42(17):3262-3266.
[10] 贾 锐,李建武,刘丽霞,等.滋肾清肝化淤方联合阿司匹林治疗子痫前期疗效及安全性研究[J].陕西中医,2019,40(6):749-752.
[11] Ye L,Shi MD,Zhang YP,et al.Risk factors and pregnancy outcomes associated with retinopathy in patients presenting with severe preeclampsia:A retrospective cohort study[J].Medicine,2020,99(11):e193-e194.
[12] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:253-260.
[13] 颜露春,朱广源,李小林,等.子痫前期孕妇外周血sFlt-1、PIGF、PP-13、sEng的表达及其与子宫动脉血流的相关性研究[J].中国生育健康杂志,2019,30(3):237-240,247.
[14] 张碧容,景少琴,郑晓丹.高甲基化SIM2基因在子痫前期诊断和严重程度及妊娠结局评估中的价值[J].中国性科学,2020,29(4):57-60.
[15] Ives CW,Sinkey R,Rajapreyar I,et al.Preeclampsia-pathophysiology and clinical presentations:Jacc state of the art review[J].Journal of the American College of Cardiology,2020,76(14):1690-1702.
[16] 刘军敏,薛艳平,白 红,等.疏肝健脾方联合胰岛素泵对肝郁脾虚型妊娠期糖尿病患者血脂、妊娠及外周血单核细胞TLR4基因影响[J].中国计划生育学杂志,2020,28(5):61-65.
[17] 侯雅莉,杜会英,谢 垒,等.可溶性ST2,NT-proBNP在妊娠期高血压疾病检测的临床意义[J].中国急救复苏与灾害医学杂志,2020,15(1):87-90.
[18] 夏 琰,赵 英.子痫前期女性胎盘及外周血中辅助T细胞及其细胞因子表达研究[J].脑与神经疾病杂志,2019,27(1):24-29.
[19] Seo MR,Chae J,Kim YM,et al.Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia[J].Lupus,2019,28(6):722-730.
[20] 赵金珩,王 茜,李 娟,等.外周血胎儿血红蛋白、胎盘生长因子及子宫动脉搏动指数对早发型子痫前期病史患者再次妊娠发病的预测价值[J].中国医药导报,2019,16(14):67-70.(收稿:2021-04-30)

备注/Memo

备注/Memo:
基金项目:山东省中医药科技发展计划项目(2019-0468)
更新日期/Last Update: 2021-09-10